DDInter1255 DDInter278
Nadolol is a nonselective beta adrenal receptor blocker that is used to lower blood pressure.[L7922,L7925] Nonselective beta adrenal receptor blockers may no longer be first line in the treatment of hypertension as newer generations of beta adrenal receptor blockers have higher selectivity and offer better rates of adverse effects. Nadolol was granted FDA approval on 10 December 1979.
Calcium lactate is a salt that consists of two lactate anions for each calcium cation (Ca2+). It is prepared commercially by the neutralization of lactic acid with calcium carbonate or calcium hydroxide. Approved by the FDA as a direct food substance affirmed as generally recognized as safe, calcium lactate is used as a firming agent, flavoring agent, leavening agent, stabilizer, and thickener . Calcium lactate is also found in daily dietary supplements as a source of calcium. It is also available in various hydrate forms, where calcium lactate pentahydrate is the most common.
Nadolol {u} (Compound) resembles {v} (Compound) Carteolol
Nadolol {u} (Compound) treats {v} (Disease) hypertension
Nadolol {u} (Compound) binds {v} (Gene) ABCB1
Nadolol {u} (Compound) upregulates {v} (Gene) EVL
Nadolol {u} (Compound) downregulates {v} (Gene) CSRP1
Nadolol {u} (Compound) causes {v} (Side Effect) Body temperature increased
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Magaldrate
Nadolol {u} may cause a minor interaction that can limit clinical effects when taken with {v} Liothyronine
Nadolol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Scopolamine
Nadolol {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pasireotide
Nadolol (Compound) resembles Carteolol (Compound)
Nadolol (Compound) treats hypertension (Disease)
Nadolol (Compound) binds ABCB1 (Gene)
Nadolol (Compound) upregulates EVL (Gene)
Nadolol (Compound) downregulates CSRP1 (Gene)
Nadolol (Compound) causes Body temperature increased (Side Effect)
Nadolol may cause a minor interaction that can limit clinical effects when taken with Magaldrate
Nadolol may cause a minor interaction that can limit clinical effects when taken with Liothyronine
Nadolol may cause a moderate interaction that could exacerbate diseases when taken with Scopolamine
Nadolol may cause a moderate interaction that could exacerbate diseases when taken with Pasireotide